The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders
Related Posts
Wu B, Woo JS, Hasiakos S, Pan C, Cokus S, Benincá C, Stiles L, Sun Z, Pellegrini M, Shirihai OS, Lusis AJ, Srikanth S, Gwack[...]
Aboulhosn J. The Ahmanson/UCLA adult congenital heart disease center, at UCLA, los angeles, USA: The history of a leading ACHD institution and its vision for[...]
Froelicher V, Husaini M, Tso JV, Montalvo S, Christle J, Perez MV, Hadley D, Wheeler M, Stein R, Vetter V, Hsu JJ, Asif IM, Hedman[...]